Items where Author or Editor is "Reinhardt, H. C." - Kölner UniversitätsPublikationsServer

Group by: Item Type | Date | No Grouping

Number of items: 18.

Journal Article

Dietlein, F., Kalb, B., Jokic, M., Torgovnick, A., Schmitt, A., Buettner, R., Thomas, R. and Reinhardt, H. C. (2015). Combined Chk1-and MK2-inhibition displays robust synergy in KRAS-mutant cancer. Oncol. Res. Treat., 38. S. 169 - 170. BASEL: KARGER. ISSN 2296-5262

Dietlein, F., Thelen, L. and Reinhardt, H. C. (2014). A functional cancer genomics screen reveals an actionable synthetic lethal interaction between the MMR gene MSH3 and the NHEJ gene PRKDC. Oncol. Res. Treat., 37. S. 298 - 300. BASEL: KARGER. ISSN 2296-5262

Huelsemann, M. F., Patz, M., Beckmann, L., Brinkmann, K., Otto, T., Fandrey, J., Becker, H. J., Theurich, S., von Bergwelt-Baildon, M., Pallasch, C. P., Zahedi, R. P., Kashkar, H., Reinhardt, H. C., Hallek, M., Wendtner, C. M. and Frenzel, L. P. (2015). Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia. Leukemia, 29 (4). S. 981 - 985. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Jachimowicz, Ron D., Klapper, Wolfram, Glehr, Gunther ORCID: 0000-0002-1495-9162, Mueller, Horst, Haverkamp, Heinz, Thorns, Christoph, Hansmann, Martin Leo, Moeller, Peter, Stein, Harald, Rehberg, Thorsten, von Tresckow, Bastian, Reinhardt, H. C., Borchmann, Peter, Chan, Fong Chun, Spang, Rainer, Scott, David W., Engert, Andreas, Steidl, Christian, Altenbuchinger, Michael and Rosenwald, Andreas (2021). Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia, 35 (12). S. 3589 - 3594. LONDON: SPRINGERNATURE. ISSN 1476-5551

Knittel, G., Korovkina, D., Liedgens, P., Fritz, C., Al-Baldawi, Y., Bahlo, J., Herling, C., Eichhorst, B., Hallek, M., Persigehl, T., Buettner, R. and Reinhardt, H. C. (2016). ESTABLISHMENT OF A PRE-CLINICAL IN VIVO PLATFORM SPANNING LOW-RISK TO HIGH-RISK CLL. Haematologica, 101. S. 9 - 11. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Knittel, G., Korovkina, D., Liedgens, P., Rehkaemper, T., Fritz, C., Torgovnick, A., Al-Baldawi, Y., Al-Maarri, M., Cun, Y., Fedorchenko, O., Riabinska, A., Beleggia, F., Nguyen, P. -H., Wunderlich, F. T., Ortmann, M., Montesinos-Rongen, M., Tausch, E., Stilgenbauer, S., Frenzel, L., Herling, M., Herling, C., Bahlo, J., Hallek, M., Peifer, M., Buettner, R., Persigehl, T. and Reinhardt, H. C. (2017). Novel models of high-risk CLL reveal an actionable PARP1 dependence in ATM-defective CLL in vivo. Oncol. Res. Treat., 40. S. 27 - 28. BASEL: KARGER. ISSN 2296-5262

Knittel, G., Liedgens, P., Korovkina, D., Seeger, J. M., Al-Baldawi, Y., Al-Maarri, M., Fritz, C., Vlantis, K., Bezhanova, S., Scheel, A. H., Wolz, O. -O., Reimann, M., Moeller, P., Lopez, C., Staudt, L. M., Ortmann, M., Pasparakis, M. ORCID: 0000-0002-9870-0966, Siebert, R., Schmitt, C. A., Klatt, A. R., Wunderlich, F. T., Schaefer, S. C., Persigehl, T., Montesinos-Rongen, M., Odenthal, M., Buettner, R., Frenzel, L. P., Kashkar, H. and Reinhardt, H. C. (2016). B cell-specific conditional expression of Myd88 p.L252P leads to the development of diffuse large B cell lymphoma in mice. Oncol. Res. Treat., 39. S. 218 - 220. BASEL: KARGER. ISSN 2296-5262

Knittel, G., Liedgens, P., Korovkina, D., Seeger, J. M., Al-Baldawi, Y., Vlantis, K., Fritz, C., Schaefer, S. C., Klatt, A., Scheel, A., Al-Maarri, M., Bezhanova, S., Montesinos-Rongen, M., Wolz, O. O., Reimann, M., Lohneis, P., Weber, A. N., Wunderlich, F. T., Pasparakis, M. ORCID: 0000-0002-9870-0966, Buettner, R., Persigehl, T., Schmitt, C. A., Odenthal, M., Frenzel, L. P., Kashkar, H. and Reinhardt, H. C. (2016). B CELL-SPECIFIC CONDITIONAL EXPRESSION OF MYD88P.L252P LEADS TO THE DEVELOPMENT OF DIFFUSE LARGE B CELL LYMPHOMA IN MICE. Haematologica, 101. S. 179 - 181. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Knittel, G., Liedgens, P. and Reinhardt, H. C. (2015). The conditional loss of Tp53 or Atm in theE mu:Tcl1 mouse leads to the development of an aggressive, chemotherapy-resistant CLL. Oncol. Res. Treat., 38. S. 200 - 201. BASEL: KARGER. ISSN 2296-5262

Lohmann, G., Vasyutina, E., Bloehdorn, J., Reinart, N., Schneider, J. I., Babu, V., Knittel, G., Crispatzu, G., Mayer, P., Prinz, C., Muenzner, J. K., Biersack, B., Efremov, D. G., Chessa, L., Herling, C. D., Stilgenbauer, S., Hallek, M., Schobert, R., Reinhardt, H. C., Schumacher, B. and Herling, M. (2017). Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia. Leukemia, 31 (5). S. 1177 - 1187. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Ratz, L., Brambillasca, C., Bartke, L., Huetzen, M., Goergens, J., Leidecker, O., Jachimowicz, R., van de Ven, M., Proost, N., Siteur, B., de Korte-Grimmerink, R., Bouwman, P., Pulver, E. M., de Bruijn, R., Isensee, J., Hucho, T., Pandey, G., van Lohuizen, M., Mallmann, P., Reinhardt, H. C., Jonkers, J. and Puppe, J. (2022). Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. Geburtshilfe Frauenheilkd., 82 (10). S. E146 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804

Riabinska, A., Schmitt, A., Fritz, C., Knittel, G., Torgovnick, A., Heneweer, C., Wittersheim, M., Frenzel, L., Wunderlich, C., Jachimowicz, R., Merseburg, A., Persigehl, T., Wunderlich, T., Buettner, R. and Reinhardt, H. C. (2017). Restoration of Atm induces lymphoma regression in vivo and is mediated by cell autonomous and non-cell autonomous mechanisms. Oncol. Res. Treat., 40. S. 40 - 41. BASEL: KARGER. ISSN 2296-5262

Schmitt, A., Knittel, G., Welcker, D., Yang, T. -P., George, J., Nowak, M., Leeser, U., Buettner, R., Perner, S., Peifer, M. and Reinhardt, H. C. (2017). ATM deficiency is associated with sensitivity to PARP1-and ATR inhibitors in lung adenocarcinoma. Oncol. Res. Treat., 40. S. 247 - 248. BASEL: KARGER. ISSN 2296-5262

Schrader, A., Crispatzu, G., Oberbeck, S., Mayer, P., Putzer, S., von Jan, J., Vasyutina, E., Warner, K., Weit, N., Pflug, N., Braun, T., Andersson, E. I., Yadav, B., Riabinska, A., Maurer, B., Ferreira, M. S. Ventura, Beier, F., Altmueller, J., Lanasa, M., Herling, C. D., Haferlach, T., Stilgenbauer, S., Hopfinger, G., Peifer, M., Bruemmendorf, T. H., Nuernberg, P., Elenitoba-Johnson, K. S. J., Zha, S., Hallek, M., Moriggl, R., Reinhardt, H. C., Stern, M. -H., Mustjoki, S., Newrzela, S., Frommolt, P. and Herling, M. (2018). Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL. Nat. Commun., 9. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Thomalla, D., Beckmann, L., Grimm, C., Oliverio, M., Meder, L., Herling, C. D., Nieper, P., Feldmann, T., Merkel, O., Lorsy, E., Guerreiro, A. da Palma, von Jan, J., Kisis, I., Wasserburger, E., Claasen, J., Faitschuk-Meyer, E., Altmueller, J., Nuernberg, P., Yang, T. -P., Lienhard, M., Herwig, R., Kreuzer, K. -A., Pallasch, C. P., Buettner, R., Schaefer, S. C., Hartley, J., Abken, H., Peifer, M., Kashkar, H., Knittel, G., Eichhorst, B., Ullrich, R. T., Herling, M., Reinhardt, H. C., Hallek, M., Schweiger, M. R. and Frenzel, L. P. (2022). Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies. Blood, 140 (20). S. 2113 - 2127. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Torgovnick, A., Heger, M. and Reinhardt, H. C. (2015). Cdkn1aSUPER mice display an increased DNA repair capacity and are protected from malignant transformation. Oncol. Res. Treat., 38. S. 169 - 170. BASEL: KARGER. ISSN 2296-5262

Wolz, O. O., Kittel, G., Cardona, Y., Herster, F., Kashkar, H., Reinhardt, H. C. and Weber, A. N. R. (2017). Impact of TLR, IL-1R and TACI receptor signaling in a MyD88 L265P mutation-driven murine model of diffuse large B cell lymphoma. Eur. J. Immunol., 47. S. 106 - 107. HOBOKEN: WILEY. ISSN 1521-4141

This list was generated on Wed Apr 24 20:49:13 2024 CEST.

Export as	Atom RSS 1.0 RSS 2.0